MDT perspectives on managing side effects associated with second-line treatment for SCLC

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life The multidisciplinary team: Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada Oncology nurse practitioner: Dr Victoria Sherry, Abramson Cancer Center, Hospital of the University of Pennsylvania, PA, USA Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA This touchPODCAST is for HCPs only.  This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/